Medytox Inc. - Net Worth and Insider Trading

Medytox Inc. Net Worth

The estimated net worth of Medytox Inc. is at least $31 Million dollars as of 2025-07-07. Medytox Inc. is the Former 10% Owner of Evolus Inc and owns about 3,381,326 shares of Evolus Inc (EOLS) stock worth over $31 Million. Details can be seen in Medytox Inc.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Medytox Inc. has not made any transactions after 2023-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Medytox Inc.

To

Medytox Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Medytox Inc. owns 1 companies in total, including Evolus Inc (EOLS) .

Click here to see the complete history of Medytox Inc.’s form 4 insider trades.

Insider Ownership Summary of Medytox Inc.

Ticker Company Transaction Date Type of Owner
EOLS Evolus Inc 2023-10-16 10 percent owner

Medytox Inc. Latest Holdings Summary

Medytox Inc. currently owns a total of 1 stock. Medytox Inc. owns 3,381,326 shares of Evolus Inc (EOLS) as of October 16, 2023, with a value of $31 Million.

Latest Holdings of Medytox Inc.

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EOLS Evolus Inc 2023-10-16 3,381,326 9.27 31,344,892

Holding Weightings of Medytox Inc.


Medytox Inc. Form 4 Trading Tracker

According to the SEC Form 4 filings, Medytox Inc. has made a total of 17 transactions in Evolus Inc (EOLS) over the past 5 years, including 8 buys and 9 sells. The most-recent trade in Evolus Inc is the sale of 1,690,663 shares on October 16, 2023, which brought Medytox Inc. around $13 Million.

Insider Trading History of Medytox Inc.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Medytox Inc. Trading Performance

GuruFocus tracks the stock performance after each of Medytox Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Medytox Inc. is -39.95%. GuruFocus also compares Medytox Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Medytox Inc. within 3 months outperforms 0 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Medytox Inc.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Medytox Inc.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -25.92 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -25.46 LIMIT LIMIT LIMIT LIMIT LIMIT

Medytox Inc. Ownership Network

Ownership Network List of Medytox Inc.

No Data

Ownership Network Relation of Medytox Inc.

Insider Network Chart


Medytox Inc. Owned Company Details

What does Evolus Inc do?

Who are the key executives at Evolus Inc?

Medytox Inc. is the 10 percent owner of Evolus Inc. Other key executives at Evolus Inc include director & See Remarks David Moatazedi , Chief Financial Officer Sandra Beaver , and See Remarks Rui Avelar .

Evolus Inc (EOLS) Insider Trades Summary

Over the past 18 months, Medytox Inc. made no insider transaction in Evolus Inc (EOLS). Other recent insider transactions involving Evolus Inc (EOLS) include a net sale of 861,812 shares made by David Moatazedi , a net sale of 30,268 shares made by Sandra Beaver , and a net sale of 66,406 shares made by Rui Avelar .

In summary, during the past 3 months, insiders sold 153,571 shares of Evolus Inc (EOLS) in total and bought 20,000 shares, with a net sale of 133,571 shares. During the past 18 months, 1,039,333 shares of Evolus Inc (EOLS) were sold and 20,000 shares were bought by its insiders, resulting in a net sale of 1,019,333 shares.

Evolus Inc (EOLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Evolus Inc Insider Transactions

No Available Data

Medytox Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Medytox Inc.. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Medytox Inc.'s mailing address is: Cheogju-si M5 28126.